AI Mental Health Apps Face Growing US Legal Scrutiny
A complex patchwork of federal and state regulations is emerging to govern AI-enabled mental health tools, creating significant compliance challenges and liability risks for developers.
Developers of AI-enabled mental health products face a rapidly evolving and complex regulatory landscape in the United States, marked by increasing scrutiny from federal agencies and a growing patchwork of state laws. This multi-front oversight creates significant compliance challenges and liability risks, including from private litigation. Sophisticated counsel should advise clients that regulatory analysis hinges on a product's specific functions and marketing claims. Key federal considerations include potential classification as a medical device by the FDA and enforcement actions by the FTC regarding deceptive claims or violations of the Health Breach Notification Rule. At the state level, a wave of new legislation imposes varied requirements for AI disclosure, crisis-response protocols, and limitations on the unauthorized practice of medicine or psychology. Furthermore, new state consumer health privacy laws add another layer of complexity. Companies in this space must proactively monitor these developments and implement robust governance, including clear user disclosures, scope controls, and meaningful human oversight to mitigate risk.